8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

______________

FORM 8-K

______________

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 30, 2018

ASPEN GROUP, INC.

(Exact name of registrant as specified in its charter)

Delaware	001-38175	27-1933597
(State or Other Jurisdiction	(Commission	(I.R.S. Employer
of Incorporation)	File Number)	Identification No.)

276 Fifth Avenue, Suite 306, New York, New York 10001

(Address of Principal Executive Office) (Zip Code)

(212) 477-1210

(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company  ¨

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Item 7.01   Regulation FD Disclosure.

On August 30, 2018, Mr. Michael Mathews, the Chairman of the Board of Directors and Chief Executive Officer of Aspen Group, Inc. (the “Company”) will deliver a presentation to certain potential investors. A copy of the presentation is furnished as Exhibit 99.1 to this report.

The information in Item 7.01 of this report, including the information in the presentation attached as Exhibit 99.1 to this report, is furnished pursuant to Item 7.01 of Form 8-K and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. Furthermore, the information in Item 7.01 of this report, including the information in the presentation attached as Exhibit 99.1 to this report, shall not be deemed to be incorporated by reference in the filings of the registrant under the Securities Act of 1933, as amended.

Item 9.01   Financial Statements and Exhibits

(d) Exhibits.

Exhibit No.	Exhibit
99.1	Investor Presentation dated August 2018

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	ASPEN GROUP, INC.
Date:  August 30, 2018	By:	/s/ Michael Mathews
		Name: Michael Mathews
		Title:   Chief Executive Officer

EX-99.1

EXHIBIT 99.1

 August, 2018Nasdaq: ASPU  1    

    2  Safe Harbor Statement  Certain statements in this presentation and responses to various questions include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding USU’s future role with family nurse practitioner’s, projected gross margins, assumptions regarding LTV, and our low customer acquisition costs and teaching costs creating favorable gross margins, and our projected annual revenue rate per campus. The words “believe,” “may,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “plan,” “could,” “target,” “potential,” “is likely,” “will,” “expect” and similar expressions, as they relate to us, are intended to identify forward-looking statements. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy and financial needs. Important factors that could cause actual results to differ from those in the forward-looking statements include the continued effectiveness of our online marketing, the ability to hold academic teaching costs in line, how students react to our hybrid pre-licensure BSN program over time, and the Company’s ability to enter into partnerships with health care organizations to establish new campuses and/or finance those campuses. Further information on our risk factors is contained in our filings with the SEC, including the 10-K dated July 13, 2018. Any forward-looking statement made by us herein speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law. Regulation G - Non-GAAP Financial Measures This presentation includes a discussion of Adjusted EBITDA, Adjusted Net Loss Per Share and Adjusted Gross Margins, non-GAAP financial measures. Certaininformation regarding these non-GAAP financial measures (including reconciliations to GAAP)is provided on the Investor Relations section of the Aspen website at www.ir.aspen.edu.  

    3  Aspen Group Vision   “To Make College Affordable Again” 

    4  Aspen Group’s Business Model  Offer world class online education at half the cost of our competitors; committed to cash-based, monthly payment plans (no interest) “Let’s Change Higher Education Forever” Online Students can pay $325/month for a Master’s degree = $11,700 (36 months) Online Students can pay $250/month for a Bachelor’s Degree = $18,000 (72 months) Online Students can pay $375/month for a Doctoral Degree = $27,000 (72 months) 

      5  Monthly Payment Model Now the Majority Payment Method at Aspen University  Recurring Monthly Tuition Billing Now Exceeds $1.2 million4,769 degree-seeking students enrolled in a monthly payment method (as of 7/31/18)Total value of monthly payment plan contracts exceeds $35 million (as of 7/31/18)   Tuition Revenues by Payment Type (last 90 days avg.): Monthly Payment Methods: 67% -Monthly Payment Plan 63% -Monthly Installment Plan 4%Cash 7%Federal Financial Aid 18%Other (Corporate Tuition Reimbursement/Military) 8%Total 100% 

   AGI Student Bodies  6 

    7  Targeting Four Growth Vectors   

    8  Growth Vector 1: RNs - Fully OnlineRN to BSN & MSN    RNs (post-licensure):BSN & MSN2.9mm RNs in U.S. Today65,000 Starts per Annum(TAM: - $478mm)**Assumes Aspen’s $7,350 LTV 

    9  Aspen University Capturing ~2%Of BSN Completion Starts   Approximately 140K RNs currently enrolled in BSN Completion programs; or approx. 50,000 new enrolls/year  

    10  Aspen University (Nursing + Other) Unit Economics Among Best In Sector   Low customer acquisition costs and variable teaching costs create highly attractive unit economics – projecting 68%+ Gross Margins at scaleAverage course completions per student enrollment is 8 = $7,350* revenue (average $820 tuition/ course today and rising), earned over 4+ yearsDirect Cost ~$2,300Student acquisition cost ~ $1,124Teaching cost ~ $1,175 (average)Hybrid faculty model (Full-Time/Adjunct Faculty)<$150 per student course completionSave ~$50,000 annual per F-T conversionGross Profit/New Student Enrollment ~ $5,050  *Assumes $600 of misc. revenue/student 

    10  Aspen University (Nursing + Other) Unit Economics Among Best In Sector   Low customer acquisition costs and variable teaching costs create highly attractive unit economics – projecting 68%+ Gross Margins at scaleAverage course completions per student enrollment is 8 = $7,350* revenue (average $820 tuition/ course today and rising), earned over 4+ yearsDirect Cost ~$2,300Student acquisition cost ~ $1,124Teaching cost ~ $1,175 (average)Hybrid faculty model (Full-Time/Adjunct Faculty)<$150 per student course completionSave ~$50,000 annual per F-T conversionGross Profit/New Student Enrollment ~ $5,050  *Assumes $600 of misc. revenue/student 

    11  Growth Vector 2: Pre-Licensure BSN Hybrid Online/Campus Program     Pre-Licensure BSN Program:(Hybrid Online/Campus Program)100,000 Pre-Licensure BSN Startsper Annum(TAM: - $3B)**Assumes Aspen’s $30,000 LTV projection 

    12  Aspen University Pre-Licensure BSN: LaunchedFirst campus in Phoenix in July, 2018  3-Year BSN program is 120 credits – 69% online, 31% on groundApproved by the AZ BON, AZPPSE, State of Colorado, DEACHave clinical partnerships in PHX (Maricopa Integrated Health System and Honor Health)Unique compared to other pre-licensure BSN programsMajority of courses onlineTuition price point (will be first <$50,000 in U.S.)9 strategically placed seminars throughout programAttitudes and behaviorsConnecting all content together with expertsFirst Semester (and academic year) already at capacity; just announced night/weekend program starting January, 2019    Forecasting $10mm+ Annual Revenue Run Rate Per Campus, 4-5 Years Out 

    13  Growth Vector 3: Doctoral Students – Fully Online     Doctoral Programs (Fully Online):55,000 Graduates per Annum14% Online Students or ~8K/yr.(TAM: - $100mm)**Assumes Aspen’s $12,600 LTV 

    14  Growth Vector 4: RNs – MSN/FNP Hybrid Online Program   USU to become the university of choice for preparing six-figure Nurse Practitioners ($27K: $375 for 72 months)    RNs (post-licensure):MSN-Family Nurse Practitioner (Hybrid Online Program)234,000 NPs in U.S. Today (8% oftotal RNs)30,000 Starts per Annum (online/hybrid and campus-based programs) (TAM: - $535mm)**Assumes Aspen’s $17,820 LTV 

 Q1 FY’19 KPI Results—Cost of Enrollment, LTV & Marketing Efficiency Ratio (MER)  15  *Based on a six-month rolling average**LTV projections are not yet available for the new BSN pre-licensure campus unit (preliminary estimate is $30,000)     Enrollments   Cost-of-Enrollment*  LTV**  MER  Aspen (Nursing + Other)  882  $1,268   $7,350  5.8X  Aspen (Doctoral)  118  $2,169   $12,600  5.8X  USU (FNP + Other)   221  $1,783   $17,820  10.0X 

 Q4 Fiscal Year 2018 Results  16  For the Quarter Ended April 30, 2018        Revenues       $ 7,225,029   Operating expenses          Cost of revenues      3,571,005     General and administrative     5,353,495     Program review settlement expense     -     Depreciation and amortization     460,314          9,384,814           Operating loss from operations       (2,159,785)  Other income (expense):          Other income     61,694     Gain on extinguishment of warrant liability     -     Interest expense     (1,566,394)    Loss on Debt Extinguishment     -         (1,504,700)  Loss from operations before income taxes       (3,664,485)  Income tax expense (benefit)       -   Net loss       $ (3,664,485)  Adjusted EBITDA       $ (1,020,004) 

    17  Equity Snapshot   Closed on $23mm equity raise on April 23, terminated $10mm credit facility following day Cash on hand ~$11.5mm (7/2018)  As of 8/27/18    Ticker on Nasdaq:  ASPU  Share Price:  $7.90  52 Week Range:  $5.35 - $9.61  Market Cap:  $145 Million  Shares Outstanding :  18.3 Million  Mgmt & BOD Ownership:  19% 

 KPI Results  18    

 Q1 FY’19 KPI Results—Enrollments  19  *Included doctoral enrollments     Q1’18  Q2’18  Q3’18  Q4’18  Q1’19  EAs  Enrolls/Month/EA  Aspen (Nursing + Other)  862*  1,044*  972*  980  882  51  5.8  Aspen (Doctoral)        116  118  5  7.9  USU (FNP + Other)        177  221  11  6.7  Aspen (Pre-Licensure BSN, AZ Campus)          93  3  10.3  NEW ENROLLMENT METHODOLOGY (Unconditional Accepts only)   Total  862  1,044  972  1,273  1,314  70   

 Q4 FY’18 - Subsidiary KPIs  20     AGI Consolidated    AU  USU  Revenues   $7,225,029   68% YOY               Ratios as a Percentage of AU Revenue  Ratios as a Percentage of USU Revenue   Instructional costs   $1,531,173      18%  38%                Marketing costs   $2,039,832      23%  35%                Gross Profit   $3,506,254      57%  27%                General & Administrative expenses  $5,353,495    27%  103% 

 Q4 FY’18 Net (Loss)/Income, Adjusted EBITDA and EPS  21     Consolidated  AGI  AU  USU  Net (Loss)/Income   $ (3,664,485)   $ (3.28M)  $ 0.9M   $(1.29M)            Adjusted EBITDA   $ (1,020,004)   $ (1.41M)  $ 1.37M   $(.98M)            Net Loss Per Share  ($0.26)                  Adjusted Net Loss Per Share*  ($0.15)        * Excluding the one time interest expense related to the early extinguishment of the $10M credit facility. 

 Net Loss to Adjusted EBITDA Reconciliation(Q4 FY’18)  Net Loss ($3,664,485)Interest Expense 1,504,701 Depreciation & Amortization 460,314 EBITDA (1,699,470) Bad Debt Expense 317,222Stock-Based Compensation 176,098Non-recurring Charges 186,146Adjusted EBITDA (Loss) ($1,020,004)  22